Search Result "A<sub>2A</sub> adenosine receptor antagonists"
A2A Adenosine Receptor Antagonists and their Potential in NeurologicalDisorders
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 28 Year: 2022 Page: 4780-4795
Author(s):
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 24 Year: 2022 Page: 4138-4151
Author(s): Stefania Gessi,Kenneth A. Jacobson,Fabrizio Vincenzi,Katia Varani,Pier A. Borea,Stefania Merighi
Adenosine A2A Receptor Antagonists as Positron Emission Tomography (PET) Tracers
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 3 Year: 2014 Page: 312-328
Author(s): S. Khanapur,A. van Waarde,K. Ishiwata,K. L. Leenders,R. A.J.O. Dierckx,P. H. Elsinga
The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 27 Year: 2014 Page: 3188-3210
Author(s): M. Jorg,P.J. Scammells,B. Capuano
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 28 Year: 2016 Page: 3224-3257
Author(s): Sara Redenti,Antonella Ciancetta,Giorgia Pastorin,Barbara Cacciari,Stefano Moro,Giampiero Spalluto,Stephanie Federico
Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Roleof Curcumin, Dopamine Agonist and Adenosine A2A Receptor Antagonist
Journal: Current Aging Science
Volume: 15 Issue: 1 Year: 2022 Page: 65-76
Author(s): Asmaa Fathy Aboul Naser,Wessam Magdi Aziz,Yomna Rashad Ahmed,Wagdy Khalil Bassaly Khalil,Manal Abdel Aziz Hamed
Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2299-2332
Author(s): Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borea, Katia Varani, Giorgia Pastorin, Tatiana Da Ros, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Giampiero Spalluto
Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 8 Year: 2015 Page: 975-988
Author(s): Jacobus P. Petzer,Anel Petzer
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias
Journal: Current Neuropharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 481-493
Author(s): Nicolas Morin,Marc Morissette,Laurent Grégoire,Thérèse Di Paolo
Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Journal: Current Drug Therapy
Volume: 10 Issue: 2 Year: 2015 Page: 66-81
Author(s): Felix-Martin Werner,Rafael Coveñas